Research Events

26 Oct 2019 - 27 Oct 2019

 

 

Dissabte 26 d’octubre

5 Nov 2019

Tiago Lopes - Unit of Mechanisms of Disease
Title: “Into the structure of human full-length Smads and the impact of cancer mutations"
Date and Time: Tuesday, 5th November 2019, 15:00h.
Place: Fèlix Seratosa, Parc Científic de Barcelona

8 Nov 2019

Organizers: IRB Barcelona
Date: Friday 8 November, 12.00h
Place: Felix Serratosa, Parc Cientific de Barcelona

Plenary Seminar

13 Nov 2019 - 15 Nov 2019

Date: 13-15 November 2019
Place: Van der Valk hotel, Nijmegen (Netherlands)

 

Early bird registration period:  April 1 – June 30, 2019

Notification of travel grants awardees:  July 31, 2019

Late registration period:  July 1 – September 16, 2019

Notification of abstract selection:  October 2019

 

Register here:

http://enablenetwork.eu/registration/

 

 

18 Nov 2019 - 20 Nov 2019

Stimulation of the immune system by blocking immunosuppressive checkpoints has shown spectacular impact in cancer therapy. There is increasing evidence that immunotherapy might elicit similar outcomes in non-oncological settings. This is the case, for example, of neurodegenerative disorders where blockade of immune checkpoints has beneficial effects.  More generally, aging is associated with a progressive unbalance in the composition and activity of the different components of the immune system.

22 Nov 2019

Organizers: IRB Barcelona
Date: Friday, 22nd November, 12.00h
Place: Fèlix Serratosa, Parc Cientific de Barcelona

Host: Marco Milán, PhD. and Jens Lüders, PhD, Group Leaders, IRB Barcelona, Mechanisms of Disease Programme.

Abstract:

27 Nov 2019

Organizers: IRB Barcelona
Date: Wednesday, 27th November, 12.00h
Place: Fèlix Serratosa, Parc Cientific de Barcelona

Host: Patrick Aloy, PhD., Group Leader, IRB Barcelona, Mechanisms of Disease Programme.

Abstract:

13 Des 2019

Ricardo Viais - Unit of Mechanisms of Disease
Title: "The role of microtubule nucleation during neural development"
Date and Time: Friday, 13th November 2019, 10:00h.
Place: Fèlix Seratosa, Parc Científic de Barcelona

15 Jun 2020 - 17 Jun 2020

Cancer is the second leading cause of death worldwide, and a problem that escalates in an aging population. Although significant progress has been made in understanding the genetic and epigenetic determinants of cancer, little attention has been paid to post-transcriptional regulation of gene expression. The process of mRNA translation shapes the proteome and plays an essential role in the reprogramming of cancerous cells, holding the promise of novel anti-cancerous therapies.